Brent L Saunders Bridge Bio Pharma, Inc. (BBIO) insider trading activity

BBIO Quotes by TradingView

Brent L Saunders is Director of BridgeBio Pharma, Inc.. Currently has a direct ownership of 17,600 shares of BBIO, which is worth approximately $448,448. The most recent transaction as insider was on Dec 29, 2021, when has been sold 17,600 shares (Common Stock) at a price of $14.48 per share, resulting in proceeds of $254,848. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.6K
0% 3M change
0% 12M change
Total Value Held $448,448

BRENT L SAUNDERS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 29 2021
BUY
Open market or private purchase
$254,848 $14.48 p/Share
17,600 Added 50.0%
17,600 Common Stock

Also insider at

CSCO
CISCO SYSTEMS, INC. Technology
Director
SKIN
Beauty Health Co Consumer Defensive
Director
SBTX
Silverback Therapeutics, Inc. Healthcare
BLCO
Bausch & Lomb Corp Healthcare
CEO and Chairman of the Board
BLS

Brent L Saunders

Director
San Jose, CA

Track Institutional and Insider Activities on BBIO

Follow BridgeBio Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BBIO shares.

Notify only if

Insider Trading

Get notified when an Bridge Bio Pharma, Inc. insider buys or sells BBIO shares.

Notify only if

News

Receive news related to BridgeBio Pharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BBIO